하이로닉 인터내셔널 웹사이트로 이동합니다.
인터내셔널 웹사이트에는 수출용 제품으로 대한민국에서 허가하지 않은 장비 및 서비스 내용을 포함하고 있습니다. 해당 내용은 대한민국의 의료기기 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC INTL. website.
The Intrrnation Web Site contains equipment and services that are not authorized by the Republic of Korea These contents are not subject to review and regulation of medical devices in Korea.
하이로닉 US 웹사이트로 이동합니다.
US 웹사이트의 내용은 "FDA"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC US website.
The contents of the US web page are about product information of items approved for "FDA". They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.
하이로닉 EU 웹사이트로 이동합니다.
EU 웹사이트의 내용은 "CE MDD 또는 CE MDR"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC EU website.
The contents of the EU(European) web page are about product information of items approved for "CEMDD or CEMDR" in EU countries. They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.
Hironic Co., Ltd. (CEO Lee Jin-woo) announced that it hosted a 'VVIP Partners Meeting' on the 20th at Park Hyatt Seoul, inviting global partner companies and Key Opinion Leaders (KOLs).
This event was organized as a platform for communication where partners and medical professionals from various countries gathered to share clinical applications of Hironic's major medical devices, thereby enhancing technological competitiveness and brand reliability. In-depth discussions on product-specific features and actual clinical cases took place on-site.
In particular, Hironic presented product details and clinical cases focusing on its core export devices: 'New Doublo 2.0', 'SYNERJET PRO™', and 'MIGLOU™'.
It was emphasized that 'New Doublo 2.0', known domestically as 'V-RO LIFTING', combines Micro-Focused Ultrasound (MFU) and Radio Frequency (RF) to enable various customized treatments tailored to individual skin conditions.
'SYNERJET PRO™', the export model of the KC-certified domestic 'SYNERJET', is an advanced medical aesthetic device that combines micro-jetting, electroporation, and plasma technologies to uniformly deliver active ingredients deep into the dermal layer.
'MIGLOU™' garnered particularly intense interest during this meeting. Introduced domestically as 'MIGLOW', this device is designed to effectively deliver energy to targeted areas while minimizing the burden on the skin's surface by applying 2.45 GHz-based Ultra High Frequency (UHF) energy technology and a cooling system. The presentation also highlighted its versatility across various areas, including the face and body, and its ability to provide customized care through multiple handpieces.
Active Q&A sessions regarding the technical characteristics, implementation feasibility, and application scope of 'MIGLOU™' took place on-site. Expectations were high for it as a next-generation aesthetic medical device due to its superior energy utilization efficiency compared to conventional RF equipment.
A representative from Hironic stated, "Through this meeting, we have reinforced our collaborative relationships with global partners, and we will continue to strive for sustained improvement in product competitiveness and the expansion of our global network."
